Home
TCRX
TCRX News

Latest TScan Therapeutics Inc. (TCRX) News on January 19, 2025

Here's Why TScan Therapeutics (TCRX) is Poised for a Turnaround After Losing -5.63% in 4 Weeks

Zacks

9 days ago

Here's Why TScan Therapeutics (TCRX) is Poised for a Turnaround After Losing -5.63% in 4 Weeks

MT Newswires

24 days ago

Sector Update: Health Care Stocks Steady Premarket Thursday

MT Newswires

24 days ago

Sector Update: Health Care

MT Newswires

24 days ago

TScan Therapeutics Signs $30 Million Direct Offering; Shares Rise Pre-Bell

TScan Therapeutics Announces $30 Million Registered Direct Offering at a 37% Premium

GlobeNewswire

24 days ago

TScan Therapeutics Announces $30 Million Registered Direct Offering at a 37% Premium

With 52% ownership, TScan Therapeutics, Inc. (NASDAQ:TCRX) boasts of strong institutional backing

Simply Wall St.

25 days ago

With 52% ownership, TScan Therapeutics, Inc. (NASDAQ:TCRX) boasts of strong institutional backing

TScan Therapeutics Refinances Existing Convertible Debt Facility with Term Loan for up to $52.5 Million from Silicon Valley Bank

GlobeNewswire

a month ago

TScan Therapeutics Refinances Existing Convertible Debt Facility with Term Loan for up to $52.5 Million from Silicon Valley Bank

TScan Therapeutics to Present Updated Data from the Ongoing ALLOHA™ Phase 1 Heme Trial During Oral Session at the 66th American Society of Hematology Annual Meeting and Exposition

GlobeNewswire

a month ago

TScan Therapeutics to Present Updated Data from the Ongoing ALLOHA™ Phase 1 Heme Trial During Oral Session at the 66th American Society of Hematology Annual Meeting and Exposition

TScan Therapeutics Named a Top Place to Work by The Boston Globe for Three Consecutive Years

GlobeNewswire

a month ago

TScan Therapeutics Named a Top Place to Work by The Boston Globe for Three Consecutive Years

TScan Therapeutics to Host Virtual KOL Event to Discuss Clinical Updates from the ALLOHA™ Phase 1 Trial and Heme Development Strategy

GlobeNewswire

2 months ago

TScan Therapeutics to Host Virtual KOL Event to Discuss Clinical Updates from the ALLOHA™ Phase 1 Trial and Heme Development Strategy

TScan Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

2 months ago

TScan Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

TScan Therapeutics, Inc. (TCRX) Reports Q3 Loss, Misses Revenue Estimates

Zacks

2 months ago

TScan Therapeutics, Inc. (TCRX) Reports Q3 Loss, Misses Revenue Estimates

TScan Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

2 months ago

TScan Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

TScan Therapeutics (TCRX) Soars 7.6%: Is Further Upside Left in the Stock?

Zacks

2 months ago

TScan Therapeutics (TCRX) Soars 7.6%: Is Further Upside Left in the Stock?

TScan Therapeutics Announces Upcoming Oral Presentation of Data from the ALLOHA™ Phase 1 Heme Trial at the 66th American Society of Hematology Annual Meeting and Exposition

GlobeNewswire

2 months ago

TScan Therapeutics Announces Upcoming Oral Presentation of Data from the ALLOHA™ Phase 1 Heme Trial at the 66th American Society of Hematology Annual Meeting and Exposition

TScan Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 39th Annual Meeting

GlobeNewswire

3 months ago

TScan Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 39th Annual Meeting

TScan Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

5 months ago

TScan Therapeutics to Participate in Upcoming Investor Conferences

Director of TScan Therapeutics Barbara Klencke Buys 18% More Shares

Simply Wall St.

5 months ago

Director of TScan Therapeutics Barbara Klencke Buys 18% More Shares

TScan Therapeutics, Inc. (TCRX) Reports Q2 Loss, Lags Revenue Estimates

Zacks

5 months ago

TScan Therapeutics, Inc. (TCRX) Reports Q2 Loss, Lags Revenue Estimates

TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

5 months ago

TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

TScan Therapeutics Decline Means Insider Profits Down To US$54k

Simply Wall St.

7 months ago

TScan Therapeutics Decline Means Insider Profits Down To US$54k

Strength Seen in Zealand Pharma AS (ZLDPF): Can Its 11.6% Jump Turn into More Strength?

Zacks

7 months ago

Strength Seen in Zealand Pharma AS (ZLDPF): Can Its 11.6% Jump Turn into More Strength?

MT Newswires

7 months ago

TScan Therapeutics Names Stephen Biggar Board Chair

TScan Therapeutics Announces Updates to its Board of Directors

GlobeNewswire

7 months ago

TScan Therapeutics Announces Updates to its Board of Directors

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

CNW Group

7 months ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

PR Newswire

7 months ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

Business Wire

7 months ago

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

New Zealand scraps plan to tax livestock burps, farts

AFP

7 months ago

New Zealand scraps plan to tax livestock burps, farts

Business Wire

7 months ago

InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

The Wall Street Journal

7 months ago

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

UK Unemployment Rises in Sign Inflationary Pressures Cool

Bloomberg

7 months ago

UK Unemployment Rises in Sign Inflationary Pressures Cool

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Simply Wall St.

7 months ago

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Business Wire

7 months ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GlobeNewswire

7 months ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23

GlobeNewswire

7 months ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Simply Wall St.

7 months ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

Reuters

7 months ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

AFP

7 months ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Enduring role of 'treasuring the past' hailed

PR Newswire

7 months ago

Enduring role of 'treasuring the past' hailed

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

GlobeNewswire

7 months ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare Conference

GlobeNewswire

8 months ago

TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare Conference

MT Newswires

8 months ago

TScan Therapeutics' Potential Blood Cancer Therapies Receive FDA Regenerative Medicine Status

TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme Malignancies

GlobeNewswire

8 months ago

TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme Malignancies

TScan Therapeutics First Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

8 months ago

TScan Therapeutics First Quarter 2024 Earnings: Misses Expectations

TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Lags Revenue Estimates

Zacks

8 months ago

TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Lags Revenue Estimates

MT Newswires

8 months ago

Janney Starts TScan Therapeutics With Buy Rating, $11 Price Target

TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

8 months ago

TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors

GlobeNewswire

8 months ago

TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors

AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks

9 months ago

AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

TScan Therapeutics, Inc. (TCRX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Zacks

9 months ago

TScan Therapeutics, Inc. (TCRX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting

GlobeNewswire

9 months ago

TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting

TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares

GlobeNewswire

9 months ago

TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares

TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting

GlobeNewswire

9 months ago

TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting

TScan Therapeutics Announces Closing of Upsized Public Offering

GlobeNewswire

9 months ago

TScan Therapeutics Announces Closing of Upsized Public Offering

TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering

GlobeNewswire

9 months ago

TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering

TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering

GlobeNewswire

9 months ago

TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering

TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities

GlobeNewswire

9 months ago

TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities

TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer

GlobeNewswire

9 months ago

TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer

TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire

10 months ago

TScan Therapeutics Announces Upcoming Presentation at the 23rd Annual Needham Virtual Healthcare Conference

Hedge funds investors control 50% of TScan Therapeutics, Inc. (NASDAQ:TCRX) and were rewarded last week after stock increased 16%

Simply Wall St.

10 months ago

Hedge funds investors control 50% of TScan Therapeutics, Inc. (NASDAQ:TCRX) and were rewarded last week after stock increased 16%

TScan Therapeutics Inc (TCRX) Reports Increased Revenue and Expands Clinical Pipeline

GuruFocus.com

10 months ago

TScan Therapeutics Inc (TCRX) Reports Increased Revenue and Expands Clinical Pipeline

TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Tops Revenue Estimates

Zacks

10 months ago

TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Tops Revenue Estimates

TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire

10 months ago

TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

TScan Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference

GlobeNewswire

a year ago

TScan Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference

TScan Therapeutics Presents Promising Updated Phase 1 Clinical Results on TSC-100 and TSC-101 at the 2024 Tandem Meetings of ASTCT and CIBMTR

GlobeNewswire

a year ago

TScan Therapeutics Presents Promising Updated Phase 1 Clinical Results on TSC-100 and TSC-101 at the 2024 Tandem Meetings of ASTCT and CIBMTR

TScan Therapeutics, Inc. (TCRX) Stock Jumps 18.1%: Will It Continue to Soar?

Zacks

a year ago

TScan Therapeutics, Inc. (TCRX) Stock Jumps 18.1%: Will It Continue to Soar?

TScan Therapeutics to Host Virtual KOL Event to Discuss Updated Results from Phase 1 Heme Malignancies Study Presented at the 2024 Tandem Meetings of ASTCT and CIBMTR

GlobeNewswire

a year ago

TScan Therapeutics to Host Virtual KOL Event to Discuss Updated Results from Phase 1 Heme Malignancies Study Presented at the 2024 Tandem Meetings of ASTCT and CIBMTR

TScan Therapeutics Expands Clinical Team with the Appointment of Dawn Pinchasik, M.D., M.S., as Vice President, Clinical Development

GlobeNewswire

a year ago

TScan Therapeutics Expands Clinical Team with the Appointment of Dawn Pinchasik, M.D., M.S., as Vice President, Clinical Development

Associated Press Finance

a year ago

Clearfield: Fiscal Q1 Earnings Snapshot

Clearfield Reports Fiscal First Quarter 2024 Results

GlobeNewswire

a year ago

Clearfield Reports Fiscal First Quarter 2024 Results

Reuters

a year ago

Biden's job approval drops to 38% as border worries rise - Reuters/Ipsos

A Massive Problem With Apple Stock Today

Motley Fool

a year ago

A Massive Problem With Apple Stock Today

TScan Therapeutics Appoints Seasoned Industry Executive Jason A. Amello as Chief Financial Officer

GlobeNewswire

a year ago

TScan Therapeutics Appoints Seasoned Industry Executive Jason A. Amello as Chief Financial Officer

OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape

GlobeNewswire

a year ago

OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape

NVE Corp's Dividend Analysis

GuruFocus.com

a year ago

NVE Corp's Dividend Analysis

ACNB Corporation Announces First Quarter Cash Dividend

GlobeNewswire

a year ago

ACNB Corporation Announces First Quarter Cash Dividend

With 33% ownership, Nautilus Biotechnology, Inc. (NASDAQ:NAUT) insiders have a lot at stake

Simply Wall St.

a year ago

With 33% ownership, Nautilus Biotechnology, Inc. (NASDAQ:NAUT) insiders have a lot at stake

Reuters

a year ago

UPDATE 4-Atomic bomb blockbuster 'Oppenheimer' leads Oscar nominations

Associated Press Finance

a year ago

RBB: Q4 Earnings Snapshot

RBB Bancorp Reports Fourth Quarter and Fiscal Year 2023 Earnings

Business Wire

a year ago

RBB Bancorp Reports Fourth Quarter and Fiscal Year 2023 Earnings

GrafTech Announces Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast

Business Wire

a year ago

GrafTech Announces Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast

loanDepot begins bringing more systems back online after cyberattack

HousingWire

a year ago

loanDepot begins bringing more systems back online after cyberattack

5 Outstanding Small Cap Value Stocks

Zacks

a year ago

5 Outstanding Small Cap Value Stocks

TScan Therapeutics Announces Best Abstracts Award and Upcoming Oral Presentation at the 2024 Tandem Meetings of ASTCT and CIBMTR

GlobeNewswire

a year ago

TScan Therapeutics Announces Best Abstracts Award and Upcoming Oral Presentation at the 2024 Tandem Meetings of ASTCT and CIBMTR

3 Pot Stocks to Avoid Like the Plague in 2024

Motley Fool

a year ago

3 Pot Stocks to Avoid Like the Plague in 2024

ACNB (ACNB) Surges 6.5%: Is This an Indication of Further Gains?

Zacks

a year ago

ACNB (ACNB) Surges 6.5%: Is This an Indication of Further Gains?

Business Wire

a year ago

Bridge Investment Group Announces Key 2024 Promotions

Oppenheimer Names Elizabeth Coolidge Head of Public Finance

PR Newswire

a year ago

Oppenheimer Names Elizabeth Coolidge Head of Public Finance

Tims China Partners with Shanghai Metro to Open Tims Coffee Shops in “Line 14” Stations

GlobeNewswire

a year ago

Tims China Partners with Shanghai Metro to Open Tims Coffee Shops in “Line 14” Stations

Sotherly Hotels Inc. Schedules Fourth Quarter 2023 Earnings Release and Conference Call

GlobeNewswire

a year ago

Sotherly Hotels Inc. Schedules Fourth Quarter 2023 Earnings Release and Conference Call

3 Turnaround Stocks With 151% to 600% Upside in 2024, According to Select Wall Street Analysts

Motley Fool

a year ago

3 Turnaround Stocks With 151% to 600% Upside in 2024, According to Select Wall Street Analysts

Reuters

a year ago

UPDATE 5-'Oppenheimer' triumphs at Golden Globes as Hollywood parties again

TScan Therapeutics Announces 2024 Clinical Plans and Highlights Recent Progress

GlobeNewswire

a year ago

TScan Therapeutics Announces 2024 Clinical Plans and Highlights Recent Progress

Should You Think About Buying DocGo Inc. (NASDAQ:DCGO) Now?

Simply Wall St.

a year ago

Should You Think About Buying DocGo Inc. (NASDAQ:DCGO) Now?

Timothy Barberich Bought 41% More Shares In TScan Therapeutics

Simply Wall St.

a year ago

Timothy Barberich Bought 41% More Shares In TScan Therapeutics

West Bancorporation, Inc. to Announce Quarterly Results, Hold Conference Call

GlobeNewswire

a year ago

West Bancorporation, Inc. to Announce Quarterly Results, Hold Conference Call

Limoneira Co (LMNR) Reports Fiscal Fourth Quarter and Full Year 2023 Results

GuruFocus.com

a year ago

Limoneira Co (LMNR) Reports Fiscal Fourth Quarter and Full Year 2023 Results

Shareholders in Funko (NASDAQ:FNKO) are in the red if they invested five years ago

Simply Wall St.

a year ago

Shareholders in Funko (NASDAQ:FNKO) are in the red if they invested five years ago

Investcorp Europe Acquisition Corp I and OpSec Group Secure Investment from SAKATA INX

Business Wire

a year ago

Investcorp Europe Acquisition Corp I and OpSec Group Secure Investment from SAKATA INX

Institutional owners may consider drastic measures as GrafTech International Ltd.'s (NYSE:EAF) recent US$100m drop adds to long-term losses

Simply Wall St.

a year ago

Institutional owners may consider drastic measures as GrafTech International Ltd.'s (NYSE:EAF) recent US$100m drop adds to long-term losses

Share on Social Networks: